108 related articles for article (PubMed ID: 7439494)
1. [Variation in high density lipoprotein cholesterol during treatment of thyroid gland diseases].
Barbier R; Paffoy JC; Venard-Sassolas A; Berthezene F
Diabete Metab; 1980 Sep; 6(3):213-7. PubMed ID: 7439494
[TBL] [Abstract][Full Text] [Related]
2. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
[TBL] [Abstract][Full Text] [Related]
4. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
5. Effects of L-thyroxine replacement therapy on carotid intima-media thickness in patients with primary hypothyroidism.
Cakal E; Turgut AT; Demirbas B; Ozkaya M; Cakal B; Serter R; Aral Y
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):294-300. PubMed ID: 19085705
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein (a) levels in thyroid dysfunction before and after treatment.
Sucić M; Bozikov V; Mesić R; Sokolić L
Croat Med J; 1998 Mar; 39(1):19-22. PubMed ID: 9475802
[TBL] [Abstract][Full Text] [Related]
7. Plasma cholesteryl ester transfer protein activity is high in infants and is not affected by thyroid hormones.
Asami T; Wada M; Uchiyama M
Metabolism; 2000 Sep; 49(9):1176-9. PubMed ID: 11016900
[TBL] [Abstract][Full Text] [Related]
8. 'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction.
de la Fuente L; Lukas JC; Vázquez JA; Jauregizar N; Calvo R; Suárez E
Eur J Clin Pharmacol; 2002 Dec; 58(9):615-9. PubMed ID: 12483454
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
Celani MF; Bonati ME; Stucci N
Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
[TBL] [Abstract][Full Text] [Related]
10. Plasma high density lipoprotein cholesterol in thyroid disease.
Agdeppa D; Macaron C; Mallik T; Schnuda ND
J Clin Endocrinol Metab; 1979 Nov; 49(5):726-9. PubMed ID: 226559
[TBL] [Abstract][Full Text] [Related]
11. High density lipoprotein and arteriosclerosis. Different patterns in primary hypothyroidism and type IIa hyperlipoproteinemia.
Brook JG; Aviram M; Luboshitzky R; Barzilai D
Isr J Med Sci; 1981 May; 17(5):318-22. PubMed ID: 7263188
[TBL] [Abstract][Full Text] [Related]
12. Central cooling effects in patients with hypercholesterolaemia.
De Lorenzo F; Mukherjee M; Kadziola Z; Sherwood R; Kakkar VV
Clin Sci (Lond); 1998 Aug; 95(2):213-7. PubMed ID: 9680504
[TBL] [Abstract][Full Text] [Related]
13. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
[TBL] [Abstract][Full Text] [Related]
14. Raised plasma endothelin-1 concentrations in patients with primary hypercholesterolemia without evidence of atherosclerosis.
Mangiafico RA; Malatino LS; Santonocito M; Spada RS; Polizzi G; Tamburino G
Int Angiol; 1996 Sep; 15(3):240-4. PubMed ID: 8971583
[TBL] [Abstract][Full Text] [Related]
15. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
[TBL] [Abstract][Full Text] [Related]
16. Changes in plasma homocysteine levels of rats with experimentally induced hypothyroidism and hyperthyroidism.
Ozkan Y; Dönder E; Güney H; Baydaş G
Neuro Endocrinol Lett; 2005 Oct; 26(5):536-40. PubMed ID: 16264404
[TBL] [Abstract][Full Text] [Related]
17. The association of serum thyroid stimulating hormone and serum lipids and lipoproteins in patients with suspected hypothyroidism.
Gomo Z; Ascott MB
Cent Afr J Med; 1994 Apr; 40(4):94-8. PubMed ID: 7954717
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of pravastatin on serum lipid levels in elderly patients with hypercholesterolemia.
Morimoto S; Koh E; Fukuo K; Higaki J; Ikegami H; Miki T; Hata T; Ogihara T
Clin Ther; 1994; 16(5):793-803. PubMed ID: 7859238
[TBL] [Abstract][Full Text] [Related]
19. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
[TBL] [Abstract][Full Text] [Related]
20. Total cholesterol/HDL-cholesterol ratio in hyperthyroidism, hypothyroidism and subclinical hypothyroidism.
Feely J; Iqbal SJ; Isles TE; Bakry M
Horm Metab Res; 1980 Oct; 12(10):560-1. PubMed ID: 7439882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
